Basys.ai
PrivateLast Round
Accelerator
Sep 16, 2024
Total Funding Raised
$2.4M
Company Overview
Basys.ai operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Pre Seed round in August 2023.
Basys.ai is a healthcare technology company that provides an AI-powered platform to streamline prior authorization and utilization management for health plans.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Workflow Automation, InsurTech, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basys.ai Comparables
Compare Basys.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anterior | 86% | |
| Banjo Health | 84% | |
| Cohere Health | 79% |
For institutional investors. Book with your work email.
Basys.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 16, 2024 | ||||
| Pre Seed | Aug 15, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Basys.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Healthworx Accelerator | Accelerator |
| Nina Capital | Pre Seed |
| Gaingels | Pre Seed |
| Chaac Ventures | Pre Seed |
| Asset Management Ventures | Pre Seed |
| Two Lanterns Venture Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Partnered with ePathUSA for CMS AI MRR pilot.
- Jan 1, 2026
Co-Founder and CEO Amber Nigam named Top Healthcare Technology CEO.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardAug 7, 2026
Basys.ai CEO and Co-founder Amber Nigam receives the 2026 Harvard Alumni Innovation Award from the Harvard T.H. Chan School of Public Health in Massachusetts on Aug 7th '26 for her leadership in applying artificial intelligence to complex healthcare challenges.
For institutional investors. Book with your work email.
Basys.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Basys.ai's valuation, stock price, and market status.
Is Basys.ai a public or private company?
Basys.ai is a private company.
What is the current stock price of Basys.ai?
Basys.ai is a private company, so its shares have no public market price. Caplight tracks Basys.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Basys.ai worth (valuation)?
Valuation information for Basys.ai is not publicly available.
Can I buy Basys.ai stock?
Basys.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Basys.ai's last funding round?
Basys.ai's most recent funding round was Accelerator on September 16, 2024.
Who are the main investors in Basys.ai?
Key investors in Basys.ai include Nina Capital.
Will Basys.ai IPO soon?
No public IPO plans have been announced for Basys.ai.
How can I track Basys.ai secondary market activity?
Caplight tracks bids, offers, and trades in Basys.ai's shares on secondary markets.